Robbins Geller Rudman & Dowd LLP has announced an investigation into Travere Therapeutics, Inc. The law firm is examining whether the company and some of its senior executives may have provided investors with false or misleading information. Investors and potential witnesses are encouraged to contact Robbins Geller for more information.
**Why this matters**
If the investigation finds that Travere Therapeutics made materially inaccurate statements, it could have legal and financial implications for the company and its leadership. Such findings may affect investor confidence and impact the company’s stock performance.